These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
131 related articles for article (PubMed ID: 37393501)
21. Pseudoginsenoside-F11 attenuates cognitive dysfunction and tau phosphorylation in sporadic Alzheimer's disease rat model. Zhu L; Hou XJ; Che XH; Zhou TS; Liu XQ; Wu CF; Yang JY Acta Pharmacol Sin; 2021 Sep; 42(9):1401-1408. PubMed ID: 33277592 [TBL] [Abstract][Full Text] [Related]
22. Intracerebroventricular Streptozotocin Injections as a Model of Alzheimer's Disease: in Search of a Relevant Mechanism. Grieb P Mol Neurobiol; 2016 Apr; 53(3):1741-1752. PubMed ID: 25744568 [TBL] [Abstract][Full Text] [Related]
23. Effect of carbamylated erythropoietin Fc fusion protein (CEPO-Fc) on learning and memory impairment and hippocampal apoptosis induced by intracerebroventricular administration of streptozotocin in rats. Moosavi M; Hooshmandi E; Javadpour P; Maghsoudi N; Katinger H; Ghasemi R Behav Brain Res; 2020 Apr; 384():112554. PubMed ID: 32057828 [TBL] [Abstract][Full Text] [Related]
24. Intracerebroventricular streptozotocin-induced Alzheimer's disease-like sleep disorders in rats: Role of the GABAergic system in the parabrachial complex. Cui SY; Song JZ; Cui XY; Hu X; Ma YN; Shi YT; Luo Y; Ge YR; Ding H; Ye H; Zhang YH CNS Neurosci Ther; 2018 Dec; 24(12):1241-1252. PubMed ID: 30014576 [TBL] [Abstract][Full Text] [Related]
25. Prenatal stress promotes icv-STZ-induced sporadic Alzheimer's pathology through central insulin signaling change. Rostami F; Javan M; Moghimi A; Haddad-Mashadrizeh A; Fereidoni M Life Sci; 2020 Jan; 241():117154. PubMed ID: 31857087 [TBL] [Abstract][Full Text] [Related]
26. Formyl Peptide Receptor 2 Deficiency Improves Cognition and Attenuates Tau Hyperphosphorylation and Astrogliosis in a Mouse Model of Alzheimer's Disease. Zhang H; Wang D; Gong P; Lin A; Zhang Y; Ye RD; Yu Y J Alzheimers Dis; 2019; 67(1):169-179. PubMed ID: 30475772 [TBL] [Abstract][Full Text] [Related]
27. A novel dual GLP-1/GIP receptor agonist alleviates cognitive decline by re-sensitizing insulin signaling in the Alzheimer icv. STZ rat model. Shi L; Zhang Z; Li L; Hölscher C Behav Brain Res; 2017 Jun; 327():65-74. PubMed ID: 28342971 [TBL] [Abstract][Full Text] [Related]
28. Neuroprotective potential of Honokiol in ICV-STZ induced neuroinflammation, Aβ Singh L; Singh S Neurosci Lett; 2023 Mar; 799():137090. PubMed ID: 36690059 [TBL] [Abstract][Full Text] [Related]
29. A non-transgenic mouse model (icv-STZ mouse) of Alzheimer's disease: similarities to and differences from the transgenic model (3xTg-AD mouse). Chen Y; Liang Z; Blanchard J; Dai CL; Sun S; Lee MH; Grundke-Iqbal I; Iqbal K; Liu F; Gong CX Mol Neurobiol; 2013 Apr; 47(2):711-25. PubMed ID: 23150171 [TBL] [Abstract][Full Text] [Related]
30. Ameliorating effect of luteolin on memory impairment in an Alzheimer's disease model. Wang H; Wang H; Cheng H; Che Z Mol Med Rep; 2016 May; 13(5):4215-20. PubMed ID: 27035793 [TBL] [Abstract][Full Text] [Related]
31. Early time course of oxidative stress in hippocampal synaptosomes and cognitive loss following impaired insulin signaling in rats: Development of sporadic Alzheimer's disease. Ansari MA; Rao MS; Al-Jarallah A; Babiker FM Brain Res; 2023 Jan; 1798():148134. PubMed ID: 36328067 [TBL] [Abstract][Full Text] [Related]
33. Improved Brain Insulin/IGF Signaling and Reduced Neuroinflammation with T3D-959 in an Experimental Model of Sporadic Alzheimer's Disease. de la Monte SM; Tong M; Schiano I; Didsbury J J Alzheimers Dis; 2017; 55(2):849-864. PubMed ID: 27802237 [TBL] [Abstract][Full Text] [Related]
34. Geniposide ameliorates learning memory deficits, reduces tau phosphorylation and decreases apoptosis via GSK3β pathway in streptozotocin-induced alzheimer rat model. Gao C; Liu Y; Jiang Y; Ding J; Li L Brain Pathol; 2014 Apr; 24(3):261-9. PubMed ID: 24329968 [TBL] [Abstract][Full Text] [Related]
35. Early and Persistent O-GlcNAc Protein Modification in the Streptozotocin Model of Alzheimer's Disease. Dos Santos JPA; Vizuete A; Hansen F; Biasibetti R; Gonçalves CA J Alzheimers Dis; 2018; 61(1):237-249. PubMed ID: 29154269 [TBL] [Abstract][Full Text] [Related]
36. Effects of thymoquinone and memantine alone and in combination on memory and hippocampal morphology in rats with streptozotocin-induced Alzheimer's disease. Özsoy Ş; Çakir Z; Akçay E; Gevrek F Turk J Med Sci; 2023 Aug; 53(4):894-901. PubMed ID: 38031940 [TBL] [Abstract][Full Text] [Related]
37. Chromium picolinate attenuates cognitive deficit in ICV-STZ rat paradigm of sporadic Alzheimer's-like dementia via targeting neuroinflammatory and IRS-1/PI3K/AKT/GSK-3β pathway. Akhtar A; Dhaliwal J; Saroj P; Uniyal A; Bishnoi M; Sah SP Inflammopharmacology; 2020 Apr; 28(2):385-400. PubMed ID: 31898080 [TBL] [Abstract][Full Text] [Related]
38. Impaired chemoreflex correlates with decreased c-Fos in respiratory brainstem centers of the streptozotocin-induced Alzheimer's disease rat model. Brown AG; Thapa M; Hooker JW; Ostrowski TD Exp Neurol; 2019 Jan; 311():285-292. PubMed ID: 30359566 [TBL] [Abstract][Full Text] [Related]
39. siRNA Mediated GSK3β Knockdown Targets Insulin Signaling Pathway and Rescues Alzheimer's Disease Pathology: Evidence from Gupta S; Singh V; Ganesh S; Singhal NK; Sandhir R ACS Appl Mater Interfaces; 2022 Jan; 14(1):69-93. PubMed ID: 34967205 [TBL] [Abstract][Full Text] [Related]
40. Beneficial effects of levetiracetam in streptozotocin-induced rat model of Alzheimer's disease. Alavi MS; Fanoudi S; Hosseini M; Sadeghnia HR Metab Brain Dis; 2022 Mar; 37(3):689-700. PubMed ID: 35098412 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]